As an expert in the field of oncology, I can provide you with information on survival rates for pancreatic cancer. It's important to note that survival rates can vary based on a number of factors, including the specific type of pancreatic cancer, the stage at diagnosis, and the treatment options available. For stage II pancreatic cancer, which is typically divided into stage IIA and IIB, the survival rate can vary. The 5-year survival rate for stage II pancreatic cancer is generally lower than that for stage II pancreatic neuroendocrine tumors (NETs), which you've mentioned. The survival rate for stage II pancreatic cancer is influenced by the tumor's size, location, and whether it has begun to invade nearby tissues or organs. The information you've provided seems to be specifically about pancreatic NETs, which are a different subset of pancreatic cancers and tend to have better survival rates compared to the more common pancreatic adenocarcinomas. For stage II pancreatic adenocarcinoma, the 5-year survival rate is unfortunately much lower, often less than 20%, due to the aggressive nature of this type of cancer. It's crucial to remember that these are general statistics and individual outcomes can vary widely. Treatment advances and personalized medicine are continually improving these rates. Patients should always discuss their prognosis with their healthcare team to understand their specific situation. read more >>

For stage II pancreatic NETs, the 5-year survival rate is about 52%. The 5-year relative survival rate for stage III pancreatic NETs is about 41%. Stage IV pancreatic NETs have a 5-year survival rate of about 16%. Still, there are often treatment options available for people with these cancers.read more >>